TherapeuticsMD Inc [TXMD] stock prices are down -6.37% to $1.47 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TXMD shares have gain 34.86% over the last week, with a monthly amount glided 9.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
TherapeuticsMD Inc [NASDAQ: TXMD] stock has seen the most recent analyst activity on August 07, 2020, when Jefferies downgraded its rating to a Underperform. Previously, JP Morgan downgraded its rating to Neutral on May 19, 2020. On December 02, 2019, Guggenheim initiated with a Buy rating. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $7 on October 17, 2019. JP Morgan started tracking with a Overweight rating for this stock on June 15, 2018, and assigned it a price target of $11. In a note dated September 08, 2017, Morgan Stanley initiated an Equal-Weight rating and provided a target price of $6 on this stock.
The stock price of TherapeuticsMD Inc [TXMD] has been fluctuating between $0.70 and $2.75 over the past year. TherapeuticsMD Inc [NASDAQ: TXMD] shares were valued at $1.47 at the most recent close of the market.
Analyzing the TXMD fundamentals
The TherapeuticsMD Inc [NASDAQ:TXMD] reported sales of 1.60M for trailing twelve months, representing a surge of 1132.08%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -3.79%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.12 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0667 points at the first support level, and at 0.6635 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1566, and for the 2nd resistance point, it is at 2.8433.
Ratios To Look Out For
It’s worth pointing out that TherapeuticsMD Inc [NASDAQ:TXMD]’s Current Ratio is 1.64. On the other hand, the Quick Ratio is 1.64, and the Cash Ratio is 0.84. Considering the valuation of this stock, the price to sales ratio is 9.92, the price to book ratio is 0.63.
Transactions by insiders
Recent insider trading involved Collins Cooper C., Director, that happened on Aug 22 ’24 when 4094.0 shares were purchased. Director, Collins Cooper C. completed a deal on Aug 21 ’24 to buy 1200.0 shares.
